2022 Publications

The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study. View Article. Cox IA, de Graaff B, Ahmed H, Campbell J, Otahal P, Corte TJ, Moodley Y, Goh N, Hopkins P, Macansh S, Walters EH, Palmer AJ. 2022. The European Journal of Health Economics.

Diagnosing interstitial lung disease by multidisciplinary discussion: A review. View Article. Glenn LM, Troy LK, Corte TJ. 2022. Frontiers in Medicine.

Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement. View Article. Cottin V, Selman M, Inoue Y, Wong AW, Corte TJ. et al. 2022. American Journal of Respiratory Critical Care Medicine.

Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective. View Article. Cottin V, Tomassetti S, Valenzuela C, Walsh SLF, Antoniou KM, Bonella F, Brown KK, Collard HR, Corte TJ. et al. 2022. American Journal of Respiratory Critical Care Medicine.

Efficacy of Pirfenidone vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data From a post-hoc Analysis. View Article. Molina-Molina M, Kreuter M, Cottin V, Corte TJ. et al. 2022. Frontiers in Medicine.

Diffuse alveolar haemorrhage as a rare complication of antiphospholipid syndrome. View Article. Seth I, Bhagavata Srinivasan SP, Bulloch G, Yi DS, Frankel A, Hsu K, Passam F, Garsia R, Corte TJ. 2022. Respirology Case Reports.

Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use. View Article. Kreuter M, Maher TM, Corte TJ. et al 2022. Advances in Therapy.

Developing a self-management package for pulmonary fibrosis: An international Delphi study. View Article. Lee JYT, Tikellis G, Khor YH, Holland AE. 2022. ERJ Open Research.

Quantitative computed tomography predicts outcomes in idiopathic pulmonary fibrosis. View Article. Humphries SM, Mackintosh JA, Jo HE, Walsh SLF, Silva M, Calandriello L, Chapman S, Ellis S, Glaspole I, Goh N, Grainge C, Hopkins PMA, Keir GJ, Moodley Y, Reynolds PN, Walters EH, Baraghoshi D, Wells AU, Lynch DA, Corte TJ. 2022. Respirology.

Lockdown as the mother of invention: disruptive technology in a disrupted time. View Article. Holland AE, Glaspole I. 2022. Lancet Respiratory Medicine.

Coagulation factor-XII induces interleukin-6 by primary lung fibroblasts: a role in idiopathic pulmonary fibrosis? View Article. Jaffar J, McMillan L, Wilson N, Panousis C, Hardy C, Cho HJ, Symons K, Glaspole I, Westall G, Wong M. 2022. American Journal of Physiology-Lung Cellular Molecular Physiology.

Physiotherapy management of interstitial lung disease. View Article. Holland AE. 2022. Journal of Physiotherapy.

Impact of Concomitant Medication Burden on Tolerability of Disease-targeted Therapy and Survival in Interstitial Lung Disease. View Article. Khor YH, Goh NSL, W(…) Ryerson CJ; CARE-PF Investigators. 2022. Annals of the American Thoracic Society.

Deep Learning-based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-resolution Computed Tomography. View Article. Walsh SL, Mackintosh JA, (…) Jo HE, Glaspole I, Grainge C, Goh N, Hopkins PMA, Moodley Y, Reynolds PN, Zappala C, Keir G, Cooper WA, Mahar AM, Ellis S, Wells AU, Corte TJ. 2022. American Journal of Respiratory and Critical Care Medicine.

Establishing CREATE: lessons learned in setting up a training environment for early career researchers in respiratory medicine. View Article. Christian K, Hey-Cunningham A, Corte T, Goh N, Jaffar J, Reynolds P, Teoh A, Troy L. 2022. BMC Medical Education.

Vascular remodelling in IPF patients and its detrimental effect on lung physiology: potential role of endothelial to mesenchymal transition (EndMT). View Article. Gaikwad A, Wenying Lu W, Dey S, Bhattarai P, Chia C, Larby J, Haug G, Myers S, Jaffar J, Westall, G, (…) Eapen M S, Sohal S S. 2022. ERJ Open Research.

Angiotensin-Converting Enzyme 2 (ACE2), Transmembrane Peptidase Serine 2 (TMPRSS2), and Furin Expression Increases in the Lungs of Patients with Idiopathic Pulmonary Fibrosis (IPF) and Lymphangioleiomyomatosis (LAM): Implications for SARS-CoV-2 (COVID-19) Infections. View Article. Lu W, Eapen MS, Singhera GK, Markos J, Haug G, Chia C, Larby J, Brake SJ, Westall GP, Jaffar J, (…) Sohal SS. 2022. Journal of Clinical Medicine.

Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in Australia. View Article. Cox IA, Otahal P, de Graaff B, Corte TJ, Moodley Y, Zappala C, Glaspole I, Hopkins P, Macansh S, Walters EH, Palmer AJ. 2022. Respirology.

Defining anti-synthetase syndrome: a systematic literature review. View Article. Zanframundo G, Faghihi-Kashani S, Scirè CA, Bonella F, Corte TJ, et al. 2022. Clinical and Experimental Rheumatology.

Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative. View Article. Hunninghake GM, (…) Corte TJ, et al.; ILA Study Group. 2022. Chest.

Barriers and facilitators to best care for idiopathic pulmonary fibrosis in Australia. View Article. Tikellis G, Corte TJ, Teoh AKY, Glaspole IN, Macansh S, Holland AE. 2022. Respirology.

Essential Features of an Interstitial Lung Disease Multidisciplinary Meeting: An International Delphi Survey. View Article. Teoh AKY, Holland AE, Morisset J, Flaherty KR, Wells AU, Walsh SLF, Glaspole I, Wuyts WA, Corte TJ; ILD MDM Delphi Collaborators. 2022. Annals of the American Thoracic Society.

Biomarker signatures for progressive idiopathic pulmonary fibrosis. View Article. Clynick B, Corte TJ, (…) Moodley Y. 2022. European Respiratory Journal.

Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis. View Article. Zheng Q, Cox IA, Campbell JA, Xia Q, Otahal P, de Graaff B, Corte TJ, Teoh AKY, Walters EH, Palmer AJ. 2022. ERJ Open Research.